Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A
dc.article.end-page | 1893 | en |
dc.article.start-page | 1880 | en |
dc.citation.doi | 10.1016/J.JTHA.2024.04.001 | en |
dc.contributor.author | B Madan | en |
dc.contributor.author | M OZELO | en |
dc.contributor.author | P Raheja | en |
dc.contributor.author | E Symington | en |
dc.contributor.author | E et al | en |
dc.contributor.author | Johnny Mahlangu | en |
dc.date.accessioned | 2024-09-29T13:39:12Z | |
dc.date.available | 2024-09-29T13:39:12Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 1538-7933 | en |
dc.identifier.uri | https://hdl.handle.net/10539/41194 | |
dc.journal.title | Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A | en |
dc.journal.volume | 22 | en |
dc.publisher | WILEY-BLACKWELL | en |
dc.title | Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 1.18 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client